In order to provide a more seamless transition of basic research into the clinic there is a pressing need to improve the reliability and physiological relevance of early screening campaigns to determine true lead compounds. Informa Life Sciences'Primary & Secondary Screening congress will set the stage for one of the key screening events of the year.

Co-located for the second year running with our Compound Library Design, Synthesis & Acquisition conference, a joint plenary session will bring together chemists and screening scientists. This will provide the rare opportunity to examine the needs and capabilities of each to look and present examples where the strengthening of the relationship can have a significant impact on the timelines and success of hit and lead discovery and optimisation phases.